
US FDA approves syringe version of Argenx’s immune disorder drug
(Reuters) -The U.S. Food and Drug Administration has approved a pre-filled syringe version of Netherlands-based Argenx SE’s blockbuster immune disorder drug, Vyvgart, giving patients the more convenient option of at-home self administration, the company …